Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy-Induced Peripheral Neuropathy (CIPN) as a Predictor of Decreased Quality of Life in Testicular Germ Cell Tumor Survivors.
Orszaghova Z, Galikova D, Lesko P, Obertova J, Rejlekova K, Sycova-Mila Z, Palacka P, Kalavska K, Svetlovska D, Mladosievicova B, Mardiak J, Mego M, Chovanec M. Orszaghova Z, et al. Among authors: svetlovska d. Clin Genitourin Cancer. 2024 Mar 2;22(3):102067. doi: 10.1016/j.clgc.2024.102067. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38555680
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.
Mego M, Danis R, Chovanec J, Jurisova S, Bystricky B, Porsok S, Konkolovsky P, Vaclav V, Wagnerova M, Streško M, Brezinova B, Rečková M, Sutekova D, Pazderova N, Novisedlakova M, Zomborska E, Ciernikova S, Svetlovska D, Drgona L. Mego M, et al. Among authors: svetlovska d. Front Oncol. 2023 Aug 4;13:1168654. doi: 10.3389/fonc.2023.1168654. eCollection 2023. Front Oncol. 2023. PMID: 37601667 Free PMC article.
Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors.
Chovanec M, Kalavska K, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Orszaghova Z, Lesko P, De Angelis V, Vasilkova L, Svetlovska D, Mladosievicova B, Mardiak J, Pastorek M, Vlkova B, Celec P, Mego M. Chovanec M, et al. Among authors: svetlovska d. Front Oncol. 2023 Mar 21;13:1146032. doi: 10.3389/fonc.2023.1146032. eCollection 2023. Front Oncol. 2023. PMID: 37025582 Free PMC article.
Changes in CoQ10/Lipids Ratio, Oxidative Stress, and Coenzyme Q10 during First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma (mUC).
Palacka P, Kucharská J, Obertová J, Rejleková K, Slopovský J, Mego M, Světlovská D, Kollárik B, Mardiak J, Gvozdjáková A. Palacka P, et al. Among authors: svetlovska d. Int J Mol Sci. 2022 Oct 28;23(21):13123. doi: 10.3390/ijms232113123. Int J Mol Sci. 2022. PMID: 36361913 Free PMC article.
Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors.
Hapakova N, Chovanec M, Rejlekova K, Kalavska K, Obertova J, Palacka P, De Angelis V, Svetlovska D, Sycova-Mila Z, Mardiak J, Mego M. Hapakova N, et al. Among authors: svetlovska d. Oncol Lett. 2022 Jul 13;24(3):308. doi: 10.3892/ol.2022.13428. eCollection 2022 Sep. Oncol Lett. 2022. PMID: 35949605 Free PMC article.
Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
Mego M, Svetlovska D, Angelis V D, Kalavska K, Lesko P, Makovník M, Obertova J, Orszaghova Z, Palacka P, Rečková M, Rejlekova K, Z SM, Mardiak J, Chovanec M. Mego M, et al. Among authors: svetlovska d. Invest New Drugs. 2022 Oct;40(5):1080-1086. doi: 10.1007/s10637-022-01271-1. Epub 2022 Jun 28. Invest New Drugs. 2022. PMID: 35763178 Clinical Trial.
Detection of Specific Immune Cell Subpopulation Changes Associated with Systemic Immune Inflammation-Index Level in Germ Cell Tumors.
Kalavska K, Sestakova Z, Mlcakova A, Gronesova P, Miskovska V, Rejlekova K, Svetlovska D, Sycova-Mila Z, Obertova J, Palacka P, Mardiak J, Chovanec M, Chovanec M, Mego M. Kalavska K, et al. Among authors: svetlovska d. Life (Basel). 2022 May 2;12(5):678. doi: 10.3390/life12050678. Life (Basel). 2022. PMID: 35629346 Free PMC article.
Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients.
Kalavska K, Sestakova Z, Mlcakova A, Gronesova P, Miskovska V, Rejlekova K, Svetlovska D, Sycova-Mila Z, Obertova J, Palacka P, Mardiak J, Chovanec M, Chovanec M, Mego M. Kalavska K, et al. Among authors: svetlovska d. Front Oncol. 2022 Mar 11;12:858797. doi: 10.3389/fonc.2022.858797. eCollection 2022. Front Oncol. 2022. PMID: 35359385 Free PMC article.
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.
Mego M, Rejlekova K, Svetlovska D, Miskovska V, Gillis AJM, De Angelis V, Kalavska K, Obertova J, Palacka P, Reckova M, Sycova-Mila Z, Pindak D, Chovanec M, Looijenga LHJ, Mardiak J. Mego M, et al. Among authors: svetlovska d. Eur Urol Open Sci. 2021 Sep 22;33:19-27. doi: 10.1016/j.euros.2021.09.002. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34738090 Free PMC article.
Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
Kalavska K, Sestakova Z, Mlcakova A, Kozics K, Gronesova P, Hurbanova L, Miskovska V, Rejlekova K, Svetlovska D, Sycova-Mila Z, Obertova J, Palacka P, Mardiak J, Chovanec M, Chovanec M, Mego M. Kalavska K, et al. Among authors: svetlovska d. Int J Mol Sci. 2021 Jul 31;22(15):8281. doi: 10.3390/ijms22158281. Int J Mol Sci. 2021. PMID: 34361047 Free PMC article.
35 results